What Did This CEO Just Do with Personal Shares of KYTH?

By George MacDonald

Yesterday, the President & CEO of Kythera, Keith Leonard, sold stocks of KYTH for $251.7k.

In addition to Leonard, 9 other KYTH executives reported Sell trades in the last month. Over the last month, Leonard has reported 3 Sell trades on KYTH for a total of 788.9k.

The company has a one year high of $$56 and a one year low of $$29.50. Currently, Kythera has an average volume of $1,202,756.00. The Company has a book value per share of 17.45.

Looking at blogger coverage of KYTH, there is a 57% Bullish tendency on the stock, in relation to a 69% average bullish tendency within the Healthcare sector.

Over the last 3 months, the insider sentiment on Kythera has been neutral based on 73 corporate insider transactions. This sentiment is higher than the average sector sentiment of insiders.

KYTHERA Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the discovery, development & commercialization of novel prescription products for the aesthetic medicine market.